Loading BSD 13F portfolios...
Elite Manager Tracking
The Top 150 BSDs
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.
Institutional Investor • Ikarian Capital
Value
$1.2B
Stocks
42 Stocks
Turnover
0.0%
Top Holdings
SLYG(9.28%) ABVX(6.51%) MRNA(5.48%) IONS(4.65%) VAXC(4.42%)
Investment philosophy details pending verification.
| Ticker | P/C | Company Name | Sector | Market Value | Shares | Weight | Chg Shares | % Chg |
|---|---|---|---|---|---|---|---|---|
| SLYG | None | SPDR SERIES TRUST | Industrials | $47.5M | 0 | 9.3% | 0 | No Change |
| ABVX | None | Abivax SA | Healthcare | $33.3M | 0 | 6.5% | 0 | No Change |
| MRNA | None | Moderna, Inc. | Health Care | $28.0M | 0 | 5.5% | 0 | No Change |
| IONS | None | Ionis Pharmaceuticals Inc | Health Care | $23.8M | 0 | 4.7% | 0 | No Change |
| VAXC | None | Vaxcyte Inc. | General | $22.6M | 0 | 4.4% | 0 | No Change |
| ANIP | None | ANI Pharmaceuticals | General | $22.5M | 0 | 4.4% | 0 | No Change |
| CLDX | None | CELLDEX THERAPEUTICS INC NEW | General | $17.8M | 0 | 3.5% | 0 | No Change |
| RCUS | None | ARCUS BIOSCIENCES INC | General | $15.6M | 0 | 3.0% | 0 | No Change |
| RLMD | None | RELMADA THERAPEUTICS INC | General | $14.9M | 0 | 2.9% | 0 | No Change |
| COGT | None | COGENT BIOSCIENCES INC | General | $14.3M | 0 | 2.8% | 0 | No Change |
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| No recent buys. | ||||
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| No recent sells. | ||||
| Sector | Stocks | Value | Exposure |
|---|---|---|---|
| General | 33 | $346.3M | 67.7% |
| Health Care | 6 | $78.8M | 15.4% |
| Industrials | 2 | $53.1M | 10.4% |
| Healthcare | 1 | $33.3M | 6.5% |